Kura Oncology, Inc. (KURA) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kura Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.976 Good day, everybody. My name is Dani, and I will be your conference operator today. 00:00:04.976 -- 00:00:10.422 At this time, I would like to welcome you to the Cura Oncology Third Quarter 2025 conference 00:00:10.422 -- 00:00:16.208 call. All lines have been placed on mute to prevent any background noises. 00:00:16.208 -- 00:00:19.471 After the speaker's remarks, there will be a question and answer session. 00:00:19.471 -- 00:00:23.255 If you would like to ask a question during this time and have joined via the webinar, 00:00:23.255 -- 00:00:29.275 please use the raised hand icon, which can be found at the bottom of your webinar application. 00:00:29.275 -- 00:00:33.865 To allow everybody the opportunity to participate, we ask that you please limit yourself 00:00:33.865 -- 00:00:38.135 to one question and then re-enter the queue for any follow-ups. 00:00:38.135 -- 00:00:43.066 At this time, I would like to turn the call over to Greg Mann from Cura Oncology. 00:00:43.066 -- 00:00:45.087 Thank you. 00:00:45.087 -- 00:00:49.976 Thank you, Danny. Good morning and welcome to Cura Oncology's third quarter 2025 conference 00:00:49.976 -- 00:00:55.045 call. Joining the call today are Dr. Troy Wilson, President and Chief Executive 00:00:55.045 -- 00:01:00.094 Officer, Tom Doyle, Senior Vice President, Finance and Accounting. 00:01:00.094 -- 00:01:05.103 Dr. Molly Leone, Chief Medical Officer, and Brian Powell, Chief Commercial Officer, 00:01:05.103 -- 00:01:08.847 are also on the call and available to answer questions. 00:01:08.847 -- 00:01:13.551 Before I turn the call over to Dr. Wilson, we remind you that today's call will include 00:01:13.551 -- 00:01:16.994 forward-looking statements based on current expectations. 00:01:16.994 -- 00:...